Before and after treatment for hypopigmented mycosis fungoides

This form of cutaneous T-cell lymphoma can present with lighter patches that may be dry, mildly scaly, or itchy. Dermatology follow-up uses the whole pattern over time, not colour alone, to assess response and decide whether the diagnosis or treatment needs re-evaluation.

Flattening, less scale, reduced itch, and no expansion can indicate better disease control even while pale areas remain visible. Repigmentation may be uneven because pigment-producing cells and skin inflammation recover on a different timetable.

A pale patch cannot be identified reliably from photographs alone. Vitiligo, eczema-related colour change, fungal conditions, and other disorders can resemble it, so diagnosis may involve examination, clinical history, and skin sampling. Repeat sampling may be considered when the course and prior findings do not align.

Use topical treatment exactly as prescribed and attend every phototherapy visit under the clinic's dosing plan. Do not add home ultraviolet exposure or tanning sessions; uncontrolled exposure can burn skin and makes the delivered dose difficult to assess.

Map the affected areas and take photographs with consistent lighting, distance, and skin position. Note itch, scale, texture, new patches, and treatment reactions. Bring this record and a current medicine list to dermatology appointments so subtle progression or improvement can be compared.

Contact your dermatology team if patches spread quickly, become thick or raised, form lumps, break down, or develop persistent pain. New swollen lymph nodes, unexplained fever, drenching night sweats, or unintentional weight loss also warrant timely assessment rather than waiting for a routine visit.

During phototherapy, report severe redness, blistering, eye symptoms, or a burn. Increasing warmth, pus, crusting, or tenderness may indicate infection and needs prompt review.

Ask which findings confirmed the diagnosis, how response will be judged when pigment is slow to return, and what change should trigger earlier review. Clarify the application plan for topical medicine, eye and skin protection during phototherapy, and how treatment will be adjusted for burning or new patches.